These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15364053)
1. Tolerance in mixed chimerism - a role for regulatory cells? Kurtz J; Wekerle T; Sykes M Trends Immunol; 2004 Oct; 25(10):518-23. PubMed ID: 15364053 [TBL] [Abstract][Full Text] [Related]
2. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts. Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139 [TBL] [Abstract][Full Text] [Related]
3. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation. Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs. Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174 [TBL] [Abstract][Full Text] [Related]
5. Recent progress in tolerance induction through mixed chimerism. Pree I; Pilat N; Wekerle T Int Arch Allergy Immunol; 2007; 144(3):254-66. PubMed ID: 17596699 [TBL] [Abstract][Full Text] [Related]
6. Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion? van Pel M; van Breugel DW; van Wijk M; Luypen S; Vingerhoed J; Roholl PJ; Boog CJ Transpl Immunol; 2003; 11(3-4):375-84. PubMed ID: 12967790 [TBL] [Abstract][Full Text] [Related]
7. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance. Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178 [TBL] [Abstract][Full Text] [Related]
8. Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance. Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R Scand J Immunol; 2009 Nov; 70(5):423-30. PubMed ID: 19874546 [TBL] [Abstract][Full Text] [Related]
9. Hurdles to the induction of tolerogenic mixed chimerism. Pilat N; Klaus C; Schwaiger E; Wekerle T Transplantation; 2009 May; 87(9 Suppl):S79-84. PubMed ID: 19424016 [TBL] [Abstract][Full Text] [Related]
10. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil. Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175 [TBL] [Abstract][Full Text] [Related]
11. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Li JM; Gorechlad J; Larsen CP; Waller EK Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205 [TBL] [Abstract][Full Text] [Related]
12. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy. Forman D; Tian C; Iacomini J Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670 [TBL] [Abstract][Full Text] [Related]
13. Tolerance induction through megadose bone marrow transplantation with two-signal blockade. Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077 [TBL] [Abstract][Full Text] [Related]
14. Tolerance and chimerism after renal and hematopoietic-cell transplantation. Scandling JD; Busque S; Dejbakhsh-Jones S; Benike C; Millan MT; Shizuru JA; Hoppe RT; Lowsky R; Engleman EG; Strober S N Engl J Med; 2008 Jan; 358(4):362-8. PubMed ID: 18216356 [TBL] [Abstract][Full Text] [Related]
15. Immune tolerance: mechanisms and application in clinical transplantation. Sykes M J Intern Med; 2007 Sep; 262(3):288-310. PubMed ID: 17697153 [TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
17. Transplantation tolerance and mixed chimerism: at the frontier of clinical application. Donckier V; Toungouz M; Goldman M Transpl Int; 2001; 14(1):1-5. PubMed ID: 11263549 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: central versus peripheral tolerance. Wekerle T; Blaha P; Koporc Z; Bigenzahn S; Pusch M; Muehlbacher F Transplantation; 2003 May; 75(9 Suppl):21S-25S. PubMed ID: 12819486 [TBL] [Abstract][Full Text] [Related]
19. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation. Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680 [TBL] [Abstract][Full Text] [Related]
20. Tolerance induction in clinical transplantation: the pending questions. Toungouz M; Donckier V; Goldman M Transplantation; 2003 May; 75(9 Suppl):58S-60S. PubMed ID: 12819494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]